ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
11K |
5.3M |
8 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
11K
|
5.3M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
11K |
5.3M |
27 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
11K
|
5.3M
|
27
|
|
ASX - By Stock
|
NEU |
Re:
Angelmans
|
|
muzza111
|
3 |
2.0K |
6 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
3
|
2.0K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Change of Director's Interest Notice - J Basile
|
|
muzza111
|
11 |
5.9K |
27 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
11
|
5.9K
|
27
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
11K |
5.3M |
10 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
11K
|
5.3M
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
11K |
5.3M |
3 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
11K
|
5.3M
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
muzza111
|
1.3K |
691K |
28 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
1.3K
|
691K
|
28
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
muzza111
|
1.3K |
691K |
17 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
1.3K
|
691K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor presentation, 15 May 2024
|
|
muzza111
|
34 |
19K |
23 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
34
|
19K
|
23
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor presentation, 15 May 2024
|
|
muzza111
|
34 |
19K |
25 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
34
|
19K
|
25
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
muzza111
|
45K |
22M |
13 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
45K
|
22M
|
13
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
muzza111
|
45K |
22M |
14 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
45K
|
22M
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren completes enrolment in Pitt Hopkins Phase 2 trial
|
|
muzza111
|
92 |
42K |
12 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
92
|
42K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
11K |
5.3M |
1 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
11K
|
5.3M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Results webinar
|
|
muzza111
|
130 |
65K |
0 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
130
|
65K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
11K |
5.3M |
11 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
11K
|
5.3M
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
11K |
5.3M |
3 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
11K
|
5.3M
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: DAYBUE net sales US$87.1 million in Q4 2023
|
|
muzza111
|
79 |
39K |
5 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
79
|
39K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
muzza111
|
316 |
168K |
7 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
316
|
168K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
muzza111
|
1.3K |
691K |
2 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
1.3K
|
691K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
muzza111
|
315 |
160K |
5 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
160K
|
5
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
muzza111
|
1.8K |
969K |
6 |
10/11/23 |
10/11/23 |
Charts
|
1.8K
|
969K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
11K |
5.3M |
17 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
11K
|
5.3M
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
muzza111
|
1.3K |
691K |
0 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
1.3K
|
691K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
11K |
5.3M |
2 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
11K
|
5.3M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
11K |
5.3M |
6 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
11K
|
5.3M
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
11K |
5.3M |
6 |
18/07/23 |
18/07/23 |
ASX - By Stock
|
11K
|
5.3M
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor web conference presentation, 14 July 2023
|
|
muzza111
|
35 |
14K |
18 |
17/07/23 |
17/07/23 |
ASX - By Stock
|
35
|
14K
|
18
|
|
ASX - By Stock
|
ARR |
Re:
Ann: Change of Director's Interest Notice
|
|
muzza111
|
30 |
10K |
5 |
19/06/23 |
19/06/23 |
ASX - By Stock
|
30
|
10K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
$4 Target
|
|
muzza111
|
129 |
42K |
10 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
129
|
42K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
11K |
5.3M |
2 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
11K
|
5.3M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Wilsons target $18.29 and summary
|
|
muzza111
|
65 |
36K |
1 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
65
|
36K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Merck to acquire Prometheus in a US$ 10.8 b deal
|
|
muzza111
|
108 |
65K |
24 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
108
|
65K
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Petra Capital 12% PT upgrade to $16.26
|
|
muzza111
|
23 |
9.2K |
3 |
17/04/23 |
17/04/23 |
ASX - By Stock
|
23
|
9.2K
|
3
|
|
ASX - By Stock
|
DRE |
Re:
General Discussion
|
|
muzza111
|
2.0K |
1.0M |
11 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
2.0K
|
1.0M
|
11
|
|
ASX - By Stock
|
ARR Mining |
Re:
Spotlight on American Rare Earths
|
|
muzza111
|
4.6K |
1.6M |
8 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
4.6K
|
1.6M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Rett Syndrome NDA accepted for Priority Review by FDA
|
|
muzza111
|
163 |
82K |
9 |
25/02/23 |
25/02/23 |
ASX - By Stock
|
163
|
82K
|
9
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
muzza111
|
45K |
22M |
1 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
45K
|
22M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
11K |
5.3M |
13 |
10/10/22 |
10/10/22 |
ASX - By Stock
|
11K
|
5.3M
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
11K |
5.3M |
15 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
11K
|
5.3M
|
15
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
muzza111
|
45K |
22M |
8 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
45K
|
22M
|
8
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
muzza111
|
45K |
22M |
5 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
45K
|
22M
|
5
|
|
ASX - By Stock
|
AKE |
Re:
EV and battery thread
|
|
muzza111
|
2.1K |
822K |
2 |
17/09/22 |
17/09/22 |
ASX - By Stock
|
2.1K
|
822K
|
2
|
|
ASX - By Stock
|
PLS |
Re:
lithium bubble bursting?
|
|
muzza111
|
70 |
47K |
3 |
17/09/22 |
17/09/22 |
ASX - By Stock
|
70
|
47K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
11K |
5.3M |
0 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
11K
|
5.3M
|
0
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
muzza111
|
45K |
22M |
0 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
45K
|
22M
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: FDA approval for Pitt Hopkins syndrome IND and Phase 2 trial
|
|
muzza111
|
30 |
15K |
4 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
30
|
15K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
muzza111
|
11K |
5.3M |
22 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
11K
|
5.3M
|
22
|
|
ASX - By Stock
|
NEU |
Re:
Neuren: Upcoming Catalysts 2022-23
|
|
muzza111
|
11 |
6.3K |
2 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
11
|
6.3K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2021 Results - a transformational year for Neuren
|
|
muzza111
|
75 |
35K |
23 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
75
|
35K
|
23
|
|